Gadopiclenol Patent Expiration

Gadopiclenol was first introduced by Guerbet in its drug Elucirem on Sep 21, 2022.

Gadopiclenol Patents

Given below is the list of patents protecting Gadopiclenol, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Elucirem US10973934 Gadolinium bearing PCTA-based contrast agents Aug 06, 2039 Guerbet
Elucirem US11590246 Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched PCTA and preparation and purification process Jan 17, 2040 Guerbet
Elucirem US8114863 Compounds comprising short aminoalcohol chains and metal complexes for medical imaging Sep 19, 2028 Guerbet

Coming Soon

Patent Strength Analyzer

Will this be useful for you?


Thank you for your response 🥳